Skye Bioscience, Inc. Common Stock (SKYE)

NASDAQ HEALTHCARE
$0.78 -8.77% RSI 45 Neutral Add Alert

Moving Averages

SMA 200
$1.52
Price below

Company Profile

Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes therapeutic drugs that modulate the endocannabinoid system. The company is headquartered in San Diego, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$27.25M
P/E Ratio
None
EPS
$-1.45
Beta
3.025
Dividend Yield
0.00%
52-Week High
$5.75
52-Week Low
$0.566

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 44.0
VRTX
Vertex Pharmaceuticals Inc
RSI 50.0
CRSP
CRISPR Therapeutics AG
RSI 55.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 62.0
MRNA
Moderna Inc
RSI 41.0
VKTX
Viking Therapeutics Inc
RSI 48.0
SRPT
Sarepta Therapeutics Inc
RSI 44.0
EDIT
Editas Medicine Inc
RSI 59.0
IOVA
Iovance Biotherapeutics Inc
RSI 54.0
NVAX
Novavax Inc
RSI 60.0

Data last updated: May 31, 2026 at 8:04 AM EDT

Track SKYE for free

Get e-mail RSI alerts when Skye Bioscience, Inc. Common Stock enters oversold or overbought territory. Free forever.

Add Alert